Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Search content at Johns Hopkins University
Home
Profiles
Research units
Research output
EBV-associated recurrent Hodgkin's disease after renal transplantation
Katherine H. Flanagan
,
Daniel C. Brennan
Research output
:
Contribution to journal
›
Article
›
peer-review
10
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'EBV-associated recurrent Hodgkin's disease after renal transplantation'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Renal Transplantation
100%
Epstein-Barr Virus
100%
Hodgkin Disease
100%
Post-transplant Lymphoproliferative Disorder
50%
Chemotherapy
16%
Renal Transplant
16%
Risk Factors
16%
Interferon-α (IFN-α)
16%
Malignancy
16%
Antiretroviral Therapy
16%
Rapamycin
16%
Remission
16%
Non-Hodgkin Lymphoma
16%
Cytotoxic T Cells
16%
Virus Load
16%
Immunosuppression Reduction
16%
Transplant Recipients
16%
Anti-CD20 Monoclonal Antibody
16%
Medicine and Dentistry
Kidney Transplantation
100%
Epstein Barr Virus
100%
Hodgkin's Lymphoma
100%
Lymphoproliferative Disease
50%
Kidney Graft
16%
Cancer
16%
Interferon
16%
Immunosuppressive Treatment
16%
Non-Hodgkin Lymphoma
16%
Cytotoxic T-Cell
16%
Rituximab
16%
Rapamycin
16%
Antiviral Therapy
16%
Chemotherapy
16%
Pathogenesis
16%
Immunology and Microbiology
Kidney Transplantation
100%
Epstein Barr Virus
100%
Lymphoproliferative Disorders
60%
Viral Load
20%
interferon
20%
Cytotoxic T Cell
20%
Immunosuppression
20%
Rituximab
20%
Sirolimus
20%